Press/Media
- 75 - 100 out of 822 results
Search results
-
-
MIL-OSI United Kingdom: expert reaction to study of a multivalent mRNA vaccine candidate as
24/11/22
1 item of Media coverage
Press/Media
-
Icahn School of Medicine at Mount Sinai Details Findings in Myeloma (Bridging Advanced Myeloma Patients To Subsequent Treatments and Clinical Trials With Classical Chemotherapy and Stem Cell Support)
Joshua Richter, Amir Steinberg, Samir Parekh & Ajai Chari
22/11/22
1 item of Media coverage
Press/Media
-
New Vaccine Approach Halts Disease After 23 Yrs of Breast Cancer
17/11/22 → 18/11/22
3 items of Media coverage
Press/Media
-
Study provides further evidence that immune cell dysregulation is a driver of COVID-19 severity
Sacha Gnjatic & Miriam Merad
18/11/22
1 item of Media coverage
Press/Media
-
Top in hem/onc: Multiple myeloma salvage therapy; revaccination guidance after cell therapy
17/11/22
1 item of Media coverage
Press/Media
-
Salvage treatments prolong survival for myeloma patients who relapse after CAR T therapy
16/11/22
1 item of Media coverage
Press/Media
-
Salvage therapies may benefit patients with multiple myeloma who relapse after CAR-T
8/11/22
1 item of Media coverage
Press/Media
-
Researchers from Icahn School of Medicine at Mount Sinai Provide Details of New Studies and Findings in the Area of Liver Cancer (Combination Transarterial Chemoembolization and Stereotactic Body Radiation Therapy for Unresectable Single Large ...)
Parissa Tabrizian, Myron Schwartz & Marcelo Facciuto
8/11/22
1 item of Media coverage
Press/Media
-
Researchers find treatment options for patients whose blood cancer relapses after CAR-T
4/11/22 → 8/11/22
8 items of Media coverage
Press/Media
-
Study finds treatment options for patients whose blood cancer relapses after CAR-T
6/11/22 → 7/11/22
4 items of Media coverage
Press/Media
-
Researchers Find Treatment Options for Patients Whose Blood Cancer Relapses Aft…
7/11/22
1 item of Media coverage
Press/Media
-
Studies from Icahn School of Medicine at Mount Sinai Update Current Data on Crohn's Disease (Neutralizing Anti-granulocyte Macrophage-colony Stimulating Factor Autoantibodies Recognize Post-translational Glycosylations On Granulocyte ...)
Ling-Shiang Chuang, Sacha Gnjatic, Ephraim Kenigsberg & Miriam Merad
7/11/22
1 item of Media coverage
Press/Media
-
Mount Sinai, Memorial Sloan Kettering find new treatment for recurring blood cancer
7/11/22
1 item of Media coverage
Press/Media
-
Addresses major gap in effectiveness of immunotherapy — The Times Of Update
6/11/22
1 item of Media coverage
Press/Media
-
Researchers Find Treatment Options for Patients Whose Blood Cancer Relapses After CAR-T
4/11/22 → 5/11/22
61 items of Media coverage
Press/Media
-
Mount Sinai Health System: Researchers Find Treatment Options for Patients Whose Blood Cancer Relapses After CAR-T
4/11/22
1 item of Media coverage
Press/Media
-
Therapy Options for Multiple Myeloma Patients Who Relapse upon Immunotherapy
4/11/22
1 item of Media coverage
Press/Media
-
Researchers Find Treatment Options for Patients Whose Blood Cancer Relapses After CAR-T.
4/11/22
1 item of Media coverage
Press/Media
-
Treatment options for patients whose blood cancer relapses after CAR-T cell therapy
4/11/22
2 items of Media coverage
Press/Media
-
Researchers identify therapies for multiple myeloma patients whose cancer relapses after CAR-T
4/11/22
1 item of Media coverage
Press/Media
-
A multinational Delphi consensus to end the COVID-19 public health threat
JOO-WON KIM & Adolfo Garcia-Sastre
3/11/22
1 item of Media coverage
Press/Media
-
Covid-19 spurred a historic vaccine R&D effort. What does it mean for future pandemics?
1/11/22
1 item of Media coverage
Press/Media
-
Targeting one immune cell type with another slows cancer growth
Brian Brown & Miriam Merad
1/11/22
1 item of Media coverage
Press/Media